Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.00043 | 1 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.00037 | 1 |